MedTrace Logo

Honey in Idiopathic Dilated Cardiomyopathy

NCT02987322 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-12-12

No results posted yet for this study

Summary

Background: Honey, as a natural product produced by honey bees, has anti-oxidant, anti-microbial, anti-inflammatory and immunomodulator properties. A few reports suggest that honey might have positive effects on cardiovascular diseases.

Methods: This was a randomized controlled study, which was carried out on 50 children, aged 2 to 12 years, suffering from idiopathic dilated cardiomyopathy (IDC). Patients were randomly assigned into two equal groups: the honey group and the control group. In the honey group, honey was provided in a dose of 1.2g/kg/day for three months in addition to the traditional treatment of IDC. The patients in the control group received only their standard treatment, without honey. The main outcome measure was the percent change in the ejection fraction (EF) and the fraction shortening (FS) shown in echocardiography.

Conditions

  • Idiopathic Dilated Cardiomyopathy

Interventions

DIETARY_SUPPLEMENT

honey

Ziziphus honey (sider honey) orally in a dose of 1ml (1.2g)/kg/day for 3 months

Sponsors & Collaborators

  • mamdouh abdulmaksoud abdulrhman

    lead OTHER

Principal Investigators

  • Waleed Elgendy, Lecturer · Ain Shams University, Pediatric departement

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-05-31
Completion
2016-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02987322 on ClinicalTrials.gov